Knobbe Martens Maintains National Top Tier Ranking for IP Litigation Work from Benchmark Litigation
IRVINE, Calif., October 28, 2025 – Knobbe Martens is proud to share that the firm and numerous partners in its Litigation practice have been recognized in the 2026 edition of...
San Diego Business Journal Names Robert Hilton and Daniel Hughes Among “Leaders of Influence in Law”
SAN DIEGO, October 21, 2025 – Knobbe Martens is pleased to share that partners Robert Hilton and Daniel Hughes have been recognized as “Leaders of Influence in Law” by the...
Lawdragon Names 17 Knobbe Martens Partners Among ‘Leading Litigators in America’
IRVINE, Calif., September 8, 2025 – Knobbe Martens is pleased to share that 17 of the firm’s partners have been recognized in the 2026 edition of the Lawdragon 500 Leading...
Knobbe Martens Partners Named Among Top Litigators “40 & Under” by Benchmark Litigation
IRVINE, Calif., August 14, 2025 – Knobbe Martens is pleased to share that partners Andrea Cheek, Kendall Loebbaka, and Adam Powell have been named to Benchmark Litigation’s 2025 “40 &...
Stephen Larson Discusses SEP-Related Antitrust Suits With IAM
Knobbe Martens partner Stephen Larson was quoted in the IAM article, “Even frivolous FRAND-related antitrust actions risk hurting SEP holders,” regarding the ongoing dispute between Samsung and ZTE Corp. over...
Settlements Don’t Close the Door: Antitrust Claims Follow IPR Challenges in Life Sciences
In the ongoing case of Carefirst of Maryland Inc. v. Johnson & Johnson[1], the plaintiffs successfully overcame a motion to dismiss. At the heart of the case is J&J’s legal...
Daniel Kamkar and Adam Powell Named Among 2024 Leaders of Influence in Law by San Diego Business Journal
SAN DIEGO, October 31, 2024 – Knobbe Martens is pleased to share that partners Daniel Kamkar and Adam Powell were profiled in San Diego Business Journal’s (SDBJ) 2024 Leaders of...
Adam Powell Named Among the Top Lawyers in California Under 40 by Daily Journal
SAN DIEGO, September 27, 2024 – Knobbe Martens is pleased to share that partner Adam Powell has been named among Daily Journal’s “Top 40 Under 40”. Mr. Powell, who serves...
Video Games and Esports: Why WIPO’s ADR is Tailored to Help Resolve IP Disputes
In this episode of the Knobbe IP+ podcast, Knobbe Martens partner Mauricio Uribe speaks with World Intellectual Property Organization (WIPO) Legal Officer Oscar Alberto Suárez Bohorquez on the recently announced...
Medtronic Acquires Intersect ENT, Sells Fiagon to Hemostasis LLC as Required by FTC
On May 13, 2022, Medtronic, Inc. announced that it completed the acquisition of Intersect ENT, Inc. The transaction was only able to gain approval of the Federal Trade Commission (FTC) upon the agreement that Medtronic sell the assets of Fiagon NA Corp., a key subsidiary of Intersect ENT. Medtronic sold Fiagon to Hemostasis LLC and was thereupon able to finalize the acquisition of Intersect ENT.
FTC v. Endo Pharms., Inc.: The D.C. District Court “Treads [the] Tenuous Line Between Patent and Antitrust Laws” to Reject the FTC’s Challenge of an Exclusive License That Allegedly Discouraged Competition
Partners Stephen Larson and Adam Powell authored “FTC v. Endo Pharms., Inc.: The D.C. District Court ‘Treads [the] Tenuous Line Between Patent and Antitrust Laws’ to Reject the FTC’s Challenge...
IP Antitrust News:
Stephen Larson and Adam Powell authored “IP Antitrust News: Fresenius Kabi USA, LLC v. Par Sterile Prods, LLC: Unasserted Patents May Break the Chain of Causation Required for Antitrust Injury,” which...
Partner Susan Natland was quoted in “Chaos is a Ladder for the Startup Lawyer,” which was published in Orange County Lawyer Magazine.
Partner Susan Natland was quoted in “Chaos is a Ladder for the Startup Lawyer,” which was published in Orange County Lawyer Magazine. Excerpt: “Securing trademark and patent assets and other IP assets...
FTC Impact Study on State Hospital Mergers to Consider Role of Certificates of Public Advantage (“COPA”)
Radhika Raman and Stephen Larson authored “FTC Impact Study on State Hospital Mergers to Consider Role of Certificates of Public Advantage (“COPA”)” which was published in AIPLA IP Antitrust News. Read the full...
